No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
www.dslyy.comNo one on the platform currently holds 603233.SS.
No tracked institution reports a position in 603233.SS as of their last filing.
No one on the platform has traded 603233.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.7% | 12.6% | 21.1% | — | — | — |
| Rev. Growth % | 3.8% | 13.5% | ||||
| Profit Margin % | 4.5% | 4.5% | 5.5% | |||
| Free Cash Flow Margin % | 17.7% | 8.8% | 6.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $29.4B | +7.4% | $1.31 | $1.29–$1.32 | — | 6 |
| 2027 | $32.3B | +9.7% | $1.51 | $1.46–$1.56 | — | 6 |
| 2028 | $35.3B | +9.4% | $1.70 | $1.42–$1.89 | — | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-24 | $0.30 | $0.36 | +20.8% |
| 2026-04-30 | $0.45 | $0.45 | +0.1% |
| 2026-04-24 | $0.08 | $0.14 | +69.0% |
| 2025-10-30 | $0.18 | $0.25 | +39.2% |
| 2025-08-28 | $0.27 | $0.30 | +10.6% |
| 2025-04-25 | $0.14 | $0.05 | -64.3% |
| 2025-04-25 | $0.31 | $0.40 | +29.0% |
| 2024-10-30 | $0.24 | $0.17 | -29.2% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 603233.SSDaShenLin Pharmaceutical Group Co., Ltd. | $18.22 | -0.87% | $20.7B | — |
| 300009.SZAnhui Anke Biotechnology (Group) Co., Ltd. | $8.02 | +0.75% | $13.4B | — |
| 300049.SZInner Mongolia Furui Medical Science Co., Ltd. | $47.81 | -0.23% | $12.6B | — |
| 300204.SZStaidson (Beijing) BioPharmaceuticals Co., Ltd. | $19.43 | -0.15% | $8.8B | — |
| 300957.SZYunnan Botanee Bio-Technology Group Co.LTD |
| $31.57 |
| +1.45% |
| $13.3B |
| — |
| 600062.SSChina Resources Double-Crane Pharmaceutical Co.,Ltd. | $15.81 | -1.06% | $16.4B | — |
| 600380.SSJoincare Pharmaceutical Group Industry Co.,Ltd. | $9.18 | -0.54% | $16.8B | — |
Source: Financial Modeling Prep · peers by sector/industry